These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Evaluation of pedigrees explained on the example of progressive muscular dystrophy]. Szibor R; Hemke G; Steinbicker V Z Arztl Fortbild (Jena); 1976 Jan; 70(2):75-8. PubMed ID: 960748 [No Abstract] [Full Text] [Related]
25. [Prenatal diagnosis of Duchenne muscular dystrophy using DNA RFLP analysis]. Zeng YT Zhonghua Yi Xue Za Zhi; 1988 Oct; 68(10):565-7, 38. PubMed ID: 2907413 [No Abstract] [Full Text] [Related]
26. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling. Bushby K; Goodship J; Haggerty D; Heald A; Walls T Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338 [No Abstract] [Full Text] [Related]
27. Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers. Vainzof M; Richard P; Herrmann R; Jimenez-Mallebrera C; Talim B; Yamamoto LU; Ledeuil C; Mein R; Abbs S; Brockington M; Romero NB; Zatz M; Topaloglu H; Voit T; Sewry C; Muntoni F; Guicheney P; Tomé FM Neuromuscul Disord; 2005 Oct; 15(9-10):588-94. PubMed ID: 16084089 [TBL] [Abstract][Full Text] [Related]
28. Complex segregation analysis and computer-assisted genetic risk assessment for Duchenne muscular dystrophy. Williams WR; Thompson MW; Morton NE Am J Med Genet; 1983 Feb; 14(2):315-33. PubMed ID: 6837627 [TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis and modern management of Duchenne muscular dystrophy. Miller RG; Hoffman EP Neurol Clin; 1994 Nov; 12(4):699-725. PubMed ID: 7845338 [TBL] [Abstract][Full Text] [Related]
30. A molecular approach to genetic counseling in the X-linked muscular dystrophies. Harper PS; Thomas NS Am J Med Genet; 1986 Dec; 25(4):687-702. PubMed ID: 2878617 [TBL] [Abstract][Full Text] [Related]
31. Genetic counseling in Becker type X-linked muscular dystrophy. I. Theoretical considerations. Grimm T Am J Med Genet; 1984 Aug; 18(4):713-8. PubMed ID: 6486169 [TBL] [Abstract][Full Text] [Related]
32. The genetics of muscular dystrophies. Harper PS Prog Med Genet; 1985; 6():53-90. PubMed ID: 3915367 [No Abstract] [Full Text] [Related]
33. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD). Zatz M; Karp LE; Rogatko A Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871 [TBL] [Abstract][Full Text] [Related]
34. Case of the month: germline mosaicism in carriers of Duchenne muscular dystrophy. Prior TW; Papp AC; Snyder PJ; Mendell JR Muscle Nerve; 1992 Aug; 15(8):960-3. PubMed ID: 1353862 [TBL] [Abstract][Full Text] [Related]
37. Effects of genetic counseling on Duchenne muscular dystrophy families in Brazil. Zatz M Am J Med Genet; 1983 Jul; 15(3):483-90. PubMed ID: 6881214 [TBL] [Abstract][Full Text] [Related]
38. Genetic counseling in Duchenne muscular dystrophy. Dennis MR; Bundey S Muscle Nerve; 1981; 4(1):81-2. PubMed ID: 7231452 [No Abstract] [Full Text] [Related]
39. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Hutton EM; Thompson MW Can Med Assoc J; 1976 Oct; 115(8):749-52. PubMed ID: 974964 [TBL] [Abstract][Full Text] [Related]